story of the week
Ravulizumab vs Eculizumab in C5-Inhibitor–Experienced Adult Patients With PNH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ravulizumab (ALXN1210) vs Eculizumab in C5-Inhibitor–Experienced Adult Patients With PNH: The 302 Study
Blood 2018 Dec 03;[EPub Ahead of Print], AG Kulasekararaj, A Hill, ST Rottinghaus, S Langemeijer, R Wells, FA Gonzalez-Fernandez, A Gaya, JW Lee, E Ojeda Gutierrez, CI Piatek, J Szer, A Risitano, S Nakao, E Bachman, L Shafner, AI Damokosh, S Ortiz, A Röth, R Peffault de LatourFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.